• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于人类乳腺癌中肿瘤相关纤维蛋白溶解的观察(作者译)

[Observations on tumor-associated fibrinolysis in human breast-cancer (author's transl)].

作者信息

Michel R T, Schmidt-Matthiesen H, Nord D, Bastert G, Gerner R

出版信息

Arch Gynakol. 1975 Dec 16;220(1):55-64. doi: 10.1007/BF00673148.

DOI:10.1007/BF00673148
PMID:174514
Abstract

In 30 cases of breast-cancer, including 24 primary cases, the tumor-associted fibrinolysis was investigated using agar plate method. In 60% of the tissue sample fibrinolytic activity was found. No activity could be detected in the remaining 40%. There was evidence of a positive correlation between tumor-associated fibrinolysis and tumor size as well as the rate of axilla metastases. Among the fibrinolytic active cases there was a disproporionate number of adenocarcinoma, whereas in the inactive collective the solid and scirrhous carcinoma prevailed. There was no relation between the tumor-associated fibrinolysis and the percentage of tumor cells in the tissue. The firbinolytic inactive tumors showed a better histopathological adaptation to the surrounding tissue than the active ones. There was less small-cell infiltrate in the stroma of the fibrinolytic active tumors than in the inactive cases. No significant difference was found in the form of growth and the occurence of fibre structure. For clinical assessment a longer period of observation and a larger study are necessary.

摘要

在30例乳腺癌患者中(包括24例原发性病例),采用琼脂平板法对肿瘤相关纤溶作用进行了研究。在60%的组织样本中发现了纤溶活性。其余40%未检测到活性。有证据表明肿瘤相关纤溶作用与肿瘤大小以及腋窝转移率之间存在正相关。在纤溶活性病例中,腺癌的比例不成比例,而在无活性的病例组中,实性癌和硬癌占主导。肿瘤相关纤溶作用与组织中肿瘤细胞的百分比之间没有关系。纤溶无活性的肿瘤在组织病理学上比活性肿瘤对周围组织的适应性更好。与无活性病例相比,纤溶活性肿瘤间质中的小细胞浸润较少。在生长形式和纤维结构的出现方面未发现显著差异。为了进行临床评估,需要更长的观察期和更大规模的研究。

相似文献

1
[Observations on tumor-associated fibrinolysis in human breast-cancer (author's transl)].关于人类乳腺癌中肿瘤相关纤维蛋白溶解的观察(作者译)
Arch Gynakol. 1975 Dec 16;220(1):55-64. doi: 10.1007/BF00673148.
2
Immunohistochemical expression of epidermal growth factor receptor in breast cancer.乳腺癌中表皮生长因子受体的免疫组织化学表达。
Breast Cancer. 2011 Jan;18(1):37-41. doi: 10.1007/s12282-010-0200-2. Epub 2010 Mar 4.
3
[Carcinoma of the breast under estrogen-treatment for prostatic carcinoma (author's transl)].前列腺癌雌激素治疗期间并发的乳腺癌(作者译)
Urologe A. 1973 Sep;12(5):249-53.
4
[Localization of mucopolysaccharides and mast cells in scirrhous carcinoma of the mamma].[乳腺硬癌中黏多糖和肥大细胞的定位]
Acta Histochem. 1969;34(1):126-37.
5
[Hydroxyproline in breast cancer].[乳腺癌中的羟脯氨酸]
Nihon Geka Gakkai Zasshi. 1989 Jun;90(6):914-9.
6
Estradiol-dependent collagenolytic enzyme activity in long-term organ culture of human breast cancer.
Cancer Res. 1975 Aug;35(8):2039-48.
7
Increased content of Type V Collagen in desmoplasia of human breast carcinoma.人乳腺癌间质中V型胶原蛋白含量增加。
Am J Pathol. 1982 Sep;108(3):276-83.
8
[Clinically occult carcinoma of the breast and the early diagnosis of breast cancer (author's transl)].[乳腺临床隐匿癌与乳腺癌的早期诊断(作者译)]
Fortschr Geb Rontgenstr Nuklearmed. 1974 May;120(5):578-87.
9
[Sexual hormone on the human mammary carcinoma cells in vitro (author's transl)].[性激素对人乳腺癌细胞的体外作用(作者译)]
Yonago Acta Med. 1973 Sep;17(2):123-32.
10
[Relation of the degree of cancerous tissue disaggregation of the breast to the spread of the tumor process].[乳腺癌变组织的解离程度与肿瘤进程扩散的关系]
Vopr Onkol. 1983;29(10):9-11.

本文引用的文献

1
Fibrinolysis in the animal organism.动物机体中的纤维蛋白溶解作用。
Nature. 1947 May 17;159(4046):681. doi: 10.1038/159681b0.
2
Properties of the fibrinokinasefibrinolysin system.纤维蛋白激酶 - 纤维蛋白溶解酶系统的特性。
Nature. 1947 Oct 25;160(4069):571. doi: 10.1038/160571a0.
3
CHARACTERISTICS OF GROWTH OF SARCOMA AND CARCINOMA CULTIVATED IN VITRO.体外培养的肉瘤和癌的生长特征。
J Exp Med. 1911 May 1;13(5):495-504. doi: 10.1084/jem.13.5.495.
4
EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.纤维蛋白溶解酶抑制剂对肺转移瘤发展的影响。
J Natl Cancer Inst. 1964 Nov;33:753-63. doi: 10.1093/jnci/33.5.753.
5
LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN TISSUES.组织中纤维蛋白溶解活性的定位
Br Med Bull. 1964 Sep;20:210-2. doi: 10.1093/oxfordjournals.bmb.a070333.
6
FIBRINOLYTIC ACTIVITY OF REPARATIVE CONNECTIVE TISSUE.修复性结缔组织的纤溶活性
J Pathol Bacteriol. 1964 Apr;87:409-14. doi: 10.1002/path.1700870221.
7
The histological localisation of fibrinolysin activator.纤维蛋白溶酶激活剂的组织学定位。
J Pathol Bacteriol. 1959 Jul;78:281-3. doi: 10.1002/path.1700780131.
8
Fibrinolysis autographs.纤维蛋白溶解图谱
Nature. 1958 Feb 15;181(4607):495-6. doi: 10.1038/181495b0.
9
Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues.动物和人体组织中纤溶酶原激活剂及胰蛋白酶抑制剂的测定。
Scand J Clin Lab Invest. 1957;9(3):233-43. doi: 10.3109/00365515709079963.
10
The fibrinolytic activity of human tissues.人体组织的纤溶活性。
Br J Haematol. 1957 Jul;3(3):284-91. doi: 10.1111/j.1365-2141.1957.tb05798.x.